✦ LIBER ✦

18 Chemotherapy or tyrosine kinase inhibitor for second line treatment in advanced non small cell lung cancer

✍ Scribed by Jyoti, B.; McKay, M.; Wong, H.; Alam, F.; Eswar, C.; Jain, P.; Littler, J.A.H.; Maguire, J.; Schofield, C.P.; Siva, A.; Ramani, V.S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-Generation Tyrosine Kinase Inhibi

✍ Roy S. Herbst 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 58 KB

Second generation tyrosine kinase inhibi

✍ Stasi, Irene; Cappuzzo, Federico 📂 Article 📅 2014 🏛 Springer (Biomed Central Ltd.) ⚖ 320 KB

Subsequent chemotherapy reverses acquire

✍ Renhua Guo; Xiaofen Chen; Tongshan Wang; Zhiyuan Zhang; Jin Sun; Yongqian Shu 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 307 KB

Second line chemotherapy (CT) in advance

✍ Westeel, V.; Jacoulet, P.; Dubiez, A.; Polio, J.C.; Pemet, D.; Depierre, A. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Second-line treatment options in advance

✍ Filippo de Marinis; Serena Ricciardi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 230 KB

Prognostic factors of second-line chemot

✍ Chang, J.H. 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 85 KB